Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

UMPIRE - Use of a Multidrug Pill In Reducing Cardiovascular Events

This study has been completed.
Sponsor:
Collaborators:
European Commission
Imperial College Healthcare NHS Trust
Royal College of Surgeons, Ireland
UMC Utrecht
The George Institute
Public Health Foundation of India
Dr. Reddy's Laboratories Limited
Information provided by (Responsible Party):
Imperial College London
ClinicalTrials.gov Identifier:
NCT01057537
First received: January 26, 2010
Last updated: November 26, 2012
Last verified: November 2012